Breaking News

You are here » Indian-Commodity  :  Economy  :  India's pharmaceutical exports rise 3% to $17.3 billion in FY18

10-Aug2018

India's pharmaceutical exports rise 3% to $17.3 billion in FY18

The commerce ministry in its latest data has showed that India's pharmaceutical exports rose only 3% to $17.3 billion in last financial year (FY18) as compared to $16.7 in FY17, while in financial year 2016 exports were $16.9 billion. The marginal rise in exports was on account of increasing regulatory concerns and pricing pressures in the global markets, including the US. Besides, import alerts by the US Food and Drug Administration, regulatory hurdles and currency fluctuation also contributed to slow growth in the overseas shipments.

The sector accounted for about 6% in the country's total exports of $303 billion in last financial year (FY18). It is one of the top five sectors in the exports segment. Generic drugs form the largest segment of the Indian pharmaceutical sector, with 75% market share (in terms of revenues). Over 55% of India's exports go to highly regulated markets.

India supplies 20% of global generic medicines in terms of volume, making the country the largest provider of generic medicines globally. The US is the top destination for Indian pharma exports, followed by the UK. America accounts for about 25% of the country's shipments. The other important destinations include South Africa, Russia, Nigeria, Brazil and Germany. Additionally, the government is working on measures to promote exports in Japan and China, tough registration and regulatory procedures there act as hindrance for domestic exporters.


Related News

View all news

Govt approves new national electronic policy 2019

With an aim to increase electronic manufacturing ecosystem in country, the government has approved a new National Electronic Policy 2019.  The objective of new electronics policy is to create......

Cabinet approves promulgation of amendments in Companies Ordinance 2019

In order to incentivize compliance with law and to extend greater Ease of Doing Business, the Union Cabinet has given green signal to the promulgating an ordinance for companies law amendments. A bill......

RBI to infuse Rs 12,500 crore into system through OMOs to increase liquidity

In order to increase liquidity into the market, the Reserve Bank of India (RBI) said it would inject Rs 12,500 crore into the system through purchase of government securities on February 21, 2019. The......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......